» Articles » PMID: 17805588

Evidence of Shared Risk for Alzheimer's Disease and Parkinson's Disease Using Family History

Overview
Journal Neurogenetics
Specialty Neurology
Date 2007 Sep 7
PMID 17805588
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This case-control study examined the potential for a common etiology of Parkinson's disease (PD) and Alzheimer's disease (AD) using reported family history. Structured interviews were used to collect AD and PD family history from subjects (n = 1,531) with AD, PD, AD/PD, or controls. Intergroup analysis compared reported AD and PD family histories in the three case groups to the histories reported in the control group. Intragroup analysis stratified each diagnostic group based on positive family history of AD, then compared the subgroups for a family history of PD. Subjects with AD had a higher risk of having a family history of AD [odds ratio (OR) 2.3; 1.5-3.4] and subjects with PD had a higher risk of having a family history of PD (OR 2.2; 1.2-4.0) as compared to control subjects. Intergroup analyses revealed no significant crossed risk, increased risk of subjects with AD having a family history of PD vs controls and vice versa. Intragroup analysis found that subjects with PD and a family history of AD were more likely to have a family history of PD (OR 1.7; 1.1-2.6) when compared to subjects with PD and no family history of AD. A similar trend was found for subjects with AD (OR 1.7; 0.9-3.1). AD and PD cases each have an increased familial risk of their respective disease. Probands with AD or PD and a family history of either disease have a higher crossed risk of a family history of the other disease. These findings suggest the existence of common genetic and/or environmental factors that predispose to both AD and PD in the subset of cases with positive family history of both neurodegenerative diseases.

Citing Articles

Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration.

Syeda T, Cannon J Chem Res Toxicol. 2022; 35(1):59-72.

PMID: 34990108 PMC: 10443083. DOI: 10.1021/acs.chemrestox.1c00274.


αS Oligomers Generated from Interactions with a Polyunsaturated Fatty Acid and a Dopamine Metabolite Differentially Interact with Aβ to Enhance Neurotoxicity.

Dhakal S, Saha J, Wyant C, Rangachari V ACS Chem Neurosci. 2021; 12(21):4153-4161.

PMID: 34665617 PMC: 8568656. DOI: 10.1021/acschemneuro.1c00530.


A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease.

Golriz Khatami S, Domingo-Fernandez D, Mubeen S, Hoyt C, Robinson C, Karki R J Alzheimers Dis. 2021; 80(2):831-840.

PMID: 33554913 PMC: 8075382. DOI: 10.3233/JAD-201397.


rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.

Santos-Reboucas C, Goncalves A, Dos Santos J, Abdala B, Motta L, Laks J Neuromolecular Med. 2017; 19(2-3):293-299.

PMID: 28567584 DOI: 10.1007/s12017-017-8444-z.


Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.

Wroolie T, Kenna H, Williams K, Rasgon N Am J Geriatr Psychiatry. 2015; 23(11):1117-26.

PMID: 26209223 PMC: 4654994. DOI: 10.1016/j.jagp.2015.05.009.


References
1.
Elbaz A, McDonnell S, Maraganore D, Strain K, Schaid D, Bower J . Validity of family history data on PD: evidence for a family information bias. Neurology. 2003; 61(1):11-7. DOI: 10.1212/01.wnl.0000068007.58423.c2. View

2.
Aarsland D, Andersen K, Larsen J, Lolk A, Kragh-Sorensen P . Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003; 60(3):387-92. DOI: 10.1001/archneur.60.3.387. View

3.
Healy D, Abou-Sleiman P, Lees A, Casas J, Quinn N, Bhatia K . Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry. 2004; 75(7):962-5. PMC: 1739086. DOI: 10.1136/jnnp.2003.026203. View

4.
Levy G, Louis E, Mejia-Santana H, Cote L, Andrews H, Harris J . Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol. 2004; 61(7):1033-9. DOI: 10.1001/archneur.61.7.1033. View

5.
Hakim A, Mathieson G . Dementia in Parkinson disease: a neuropathologic study. Neurology. 1979; 29(9 Pt 1):1209-14. DOI: 10.1212/wnl.29.9_part_1.1209. View